Concepedia

Éric Jourdan

ÉJ

Statistics

Publications

51

Citations

4.5K

H-Index

29

Active since

1994

Affiliations

Inserm(Current)

Centre Hospitalier Universitaire de Nîmes

Hôpital Saint-Louis

Centre Hospitalier Universitaire d'Angers

Assistance Publique – Hôpitaux de Paris

Éric Jourdan is an author at Inserm specializing in medicine, oncology, and hematology.

Publications per year

1994–2024

51

Publications

51

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone

Jérôme Moreaux, Éric Legouffe, Éric Jourdan et al. · Blood · 2003 · 567 citations · Full text

, , +14

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

Claude Preudhomme, Joëlle Guilhot, Franck E. Nicolini et al. · New England Journal of Medicine · 2010 · 386 citations

, , +6

Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia

Éric Jourdan, Nicolas Boissel, Sylvie Chevret et al. · Blood · 2013 · 357 citations

, , +16

Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL

Philippe Rousselot, marie Magdelaine Coude, Nicola Gökbuget et al. · Blood · 2016 · 326 citations · Full text

, , +9

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

Delphine Rossille, M Gréssier, Diane Damotte et al. · Leukemia · 2014 · 324 citations

, , +14

1–5 of 51